BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8377997)

  • 1. Intestinal and pelvic endometriosis presenting as a tumor and associated with tamoxifen therapy: report of a case.
    Hajjar LR; Kim W; Nolan GH; Turner S; Raju UR
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):642-4. PubMed ID: 8377997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endometriosis in tamoxifen therapy].
    Fuith LC; Pflanzl W
    Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):354-5. PubMed ID: 7657147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature.
    Cohen I; Altaras MM; Lew S; Tepper R; Beyth Y; Ben-Baruch G
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):443-7. PubMed ID: 7835785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.
    Rose PG; Alvarez B; Maclennan GT
    Am J Obstet Gynecol; 2000 Aug; 183(2):507-8. PubMed ID: 10942499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-menopausal endometriosis developed during tamoxifen treatment].
    Le Bouëdec G; Kauffmann P; Pingeon JM; de Latour M; Lemesle P; Dauplat J
    Rev Fr Gynecol Obstet; 1991 May; 86(5):407-10. PubMed ID: 1871504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy-a case to illustrate features on magnetic resonance imaging.
    Kraft JK; Hughes T
    Clin Radiol; 2006 Feb; 61(2):198-201. PubMed ID: 16439226
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE
    Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intestinal endometriosis].
    Gubler C
    Schweiz Med Wochenschr; 1983 Dec; 113(51):1970-2. PubMed ID: 6658434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Florid polypoid endometriosis exacerbated by tamoxifen therapy in breast cancer.
    Chang CK; Chen P; Leu FJ; Lou SM
    Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1127-30. PubMed ID: 14607030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Lee JH; Recht A
    J Clin Oncol; 2003 Jun; 21(12):2260-7. PubMed ID: 12805324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. Stockholm Breast Cancer Study Group.
    Dalberg K; Johansson H; Johansson U; Rutqvist LE
    Cancer; 1998 Jun; 82(11):2204-11. PubMed ID: 9610700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
    Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometriosis and tamoxifen therapy.
    Morgan MA; Gincherman Y; Mikuta JJ
    Int J Gynaecol Obstet; 1994 Apr; 45(1):55-7. PubMed ID: 7913061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulosa cell tumor of the ovary associated with antecedent tamoxifen use.
    Gherman RB; Parker MF; Macri CI
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):717-9. PubMed ID: 9205462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
    Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
    Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.